A bill aimed at increasing transparency in how pharmacy benefit managers operate advanced out of the Senate Insurance Committee Wednesday, signaling a push to regulate an industry that critics say drives up drug prices and puts local pharmacies at risk.
House Bill 264, authored by Rep. Michael Echols, R-Monroe, cleared the committee with amendments that would ban pricing schemes, strengthen oversig…